Tonix Pharmaceuticals Holding, based in Chatham, New Jersey, specializes in developing therapeutics for CNS disorders and immunology, with a portfolio including TNX-102 SL for fibromyalgia and TNX-1500 for autoimmune diseases. Founded in 2010, the company employs 103 people and markets Zembrace SymTouch and Tosymra.
TNXP filed a patent for "eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride" on Tue, October 31, 2023. The patent was officially published on Thu, September 26, 2024.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
